Passage Bio (PASG)
(Delayed Data from NSDQ)
$5.74 USD
0.00 (0.00%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $5.70 -0.04 (-0.70%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Passage Bio, Inc. has a market cap of $17.91M, which represents its share price of $5.74 multiplied by its outstanding shares number of 3.12M. As a small-cap company, PASG's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PASG 5.74 0.00(0.00%)
Will PASG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PASG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PASG
Passage Bio (PASG) Upgraded to Buy: Here's What You Should Know
PASG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for PASG
12 Health Care Stocks Moving In Friday's Intraday Session
Passage Bio (PASG) Trading Halted Amid Upcoming Announcement | PASG Stock News
Passage Bio trading halted, news pending
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Passage Bio to implement 1-for-20 reverse stock split